InflaRx (IFRX) shares sank 60% after the company said Wednesday it plans to discontinue development of vilobelimab in pyoderma gangrenosum, a rare and inflammatory skin disease.
More than 5.48 million shares traded intraday, compared with a daily average of about 301,000.
Cemtrex (CETX) said it priced a firm commitment underwritten public offering of 1.25 million shares at $1.00 apiece.
Shares slumped 46%, with intraday trading volume of over 2.56 million against a daily average of about 299,000.
Exodus Movement (EXOD) filed a registration statement late Tuesday for the sale of up to $1 billion of securities, including class A stock and debt, from time to time.
Shares dropped 21% as intraday trading volume rose to more than 220,000 from a daily average of roughly 96,000.
Price: 0.73, Change: -1.09, Percent Change: -59.89
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。